Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bridget P Keenan

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Cancer Discovery|May 18, 2021
Conditional Cancer Immunotherapy as a Safer Way to Step on the GasBridget P Keenan, Lawrence Fong
Seminars in Oncology|May 19, 2012
Whole cell vaccines--past progress and future strategiesBridget P Keenan, Elizabeth M Jaffee
Journal for Immunotherapy of Cancer|October 20, 2019
Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune responseBridget P Keenan, Lawrence Fong, Robin K Kelley
Cancer Immunology Research|January 11, 2014
Tumor immunology: multidisciplinary science driving basic and clinical advancesBridget P Keenan, Elizabeth M Jaffee, Todd D Armstrong
Clinical Genitourinary Cancer|October 31, 2025
Oral Toxicities of PSMA-Targeted Therapies: Mitigation Strategies and Translational OpportunitiesChitra Priya Emperumal, Nagarajan Kannan, Daniel S Childs, et al.
The Journal of Biological Chemistry|April 6, 2005
A hairpin-like structure within an AU-rich mRNA-destabilizing element regulates trans-factor binding selectivity and mRNA decay kineticsElizabeth J Fialcowitz, Brandy Y Brewer, Bridget P Keenan, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 8, 2023
Structural Sexism and Cancer Care: The Effects on the Patient and OncologistBridget P Keenan, Elizabeth Barr, Elizabeth Gleeson, et al.
Drugs|July 4, 2023
New Opportunities to Individualize Frontline Therapy in Advanced Stages of Hepatocellular CarcinomaJohn D Gordan, Bridget P Keenan, Huat Chye Lim, et al.
BMC Medical Education|April 5, 2024
Creation of a sustainable longitudinal women in Leadership Development (WILD) curriculum focused on graduate medical education traineesColleen A McGourty, Francine Castillo, Grace Donzelli, et al.
Journal of Hepatology|August 27, 2025
New targets and new drugs for hepatobiliary cancersStephen L Chan, Angela Lamarca, Chiun Hsu, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Cancer Discovery|May 18, 2021
Conditional Cancer Immunotherapy as a Safer Way to Step on the GasBridget P Keenan, Lawrence Fong
Seminars in Oncology|May 19, 2012
Whole cell vaccines--past progress and future strategiesBridget P Keenan, Elizabeth M Jaffee
Journal for Immunotherapy of Cancer|October 20, 2019
Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune responseBridget P Keenan, Lawrence Fong, Robin K Kelley
Cancer Immunology Research|January 11, 2014
Tumor immunology: multidisciplinary science driving basic and clinical advancesBridget P Keenan, Elizabeth M Jaffee, Todd D Armstrong
Clinical Genitourinary Cancer|October 31, 2025
Oral Toxicities of PSMA-Targeted Therapies: Mitigation Strategies and Translational OpportunitiesChitra Priya Emperumal, Nagarajan Kannan, Daniel S Childs, et al.
The Journal of Biological Chemistry|April 6, 2005
A hairpin-like structure within an AU-rich mRNA-destabilizing element regulates trans-factor binding selectivity and mRNA decay kineticsElizabeth J Fialcowitz, Brandy Y Brewer, Bridget P Keenan, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 8, 2023
Structural Sexism and Cancer Care: The Effects on the Patient and OncologistBridget P Keenan, Elizabeth Barr, Elizabeth Gleeson, et al.
Drugs|July 4, 2023
New Opportunities to Individualize Frontline Therapy in Advanced Stages of Hepatocellular CarcinomaJohn D Gordan, Bridget P Keenan, Huat Chye Lim, et al.
BMC Medical Education|April 5, 2024
Creation of a sustainable longitudinal women in Leadership Development (WILD) curriculum focused on graduate medical education traineesColleen A McGourty, Francine Castillo, Grace Donzelli, et al.
Journal of Hepatology|August 27, 2025
New targets and new drugs for hepatobiliary cancersStephen L Chan, Angela Lamarca, Chiun Hsu, et al.
Pageof 3